Herzliya Medical Center is a trusted healthcare provider for Nasopharyngeal Cancer Treatment, offering multidisciplinary cancer care supported by experienced oncologists and modern medical infrastructure. Established in 1983, the hospital is situated in Herzliya, Israel and has 120 beds.

Nasopharyngeal Cancer develops in the tissues of the nasopharynx, the area behind the nose and above the throat. Treatment is selected according to the cancer stage and may include radiotherapy, chemotherapy, targeted therapy, or immunotherapy in appropriate cases. A detailed diagnostic evaluation, including biopsy and imaging, is generally performed before treatment planning. Patients may also receive supportive care to manage symptoms and treatment-related effects throughout their cancer journey.